ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1601

Role of Focal Adhesion Kinase in Synovial Fibroblast Invasion and Arthritis

Miriam A. Shelef1, David Bennin2 and Anna Huttenlocher3, 1Medicine, Univ of Wisconsin Schl of Med, Madison, WI, 2Pediatrics and MMI, Univ of Wisconsin Schl of Med, Madison, WI, 3Dept of Pediatrics and MMI, Univ of Wisconsin Schl of Med, Madison, WI

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: rheumatoid arthritis (RA) and synovial cells, synovial fluid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cell-cell Adhesion, Cell Trafficking and Angiogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid arthritis is an inflammatory arthritis characterized by joint erosions and destruction. This damage is mediated in part by invasion of synovial fibroblasts into cartilage and bone. Cellular invasion has been extensively studied in cancer cells, but we are just beginning to understand the elements necessary for synovial fibroblast invasion. Focal adhesion kinase (FAK) is a protein scaffold and tyrosine kinase important for cancer cell migration and invasion. FAK may also play a role in synovial fibroblast invasion and arthritis. Phosphorylated FAK is increased in rheumatoid synovial tissue and localizes to focal adhesions in rheumatoid synovial fibroblasts. Also, FAK mediates IL-6 induction and is expressed in endothelial and immune cells. FAK inhibitors are in clinical trials for cancer, so if FAK were important for synovial fibroblast invasion and arthritis, FAK inhibitors might also be of benefit for treating rheumatoid arthritis.

Methods: Synovial fibroblasts derived from the synovial fluid of patients with rheumatoid arthritis were treated with vehicle control or two different FAK inhibitors, PF 562271 and PF 573228, and plated on Matrigel invasion chambers to assess the role of FAK in invasion. To dissect which steps of invasion require FAK activity, we assessed migration using fibronectin coated transwells and focal matrix degradation by plating synovial fibroblasts on coverslips coated with fluorescent gelatin. To determine the role of FAK in arthritis, we crossed established lines of mice to generate mice that overexpress TNFα, express tamoxifen inducible Cre recombinase, and carry FAK flanked by LoxP sites. These TNF+Cre+FAKf/fmice spontaneously get arthritis due to overexpression of TNFα and can be induced to delete FAK by treatment with tamoxifen. Western blots were done to assess loss of FAK protein in splenocytes after tamoxifen treatment. Arthritis was assessed in FAK deficient and control arthritic mice by scoring paw swelling and deformity as well as testing grip strength from 2 to 5 months of age.

Results: Inhibition of FAK using either PF 562271 or PF 573228 resulted in decreased rheumatoid synovial fibroblast invasion through Matrigel and decreased migration through fibronectin coated transwells compared to vehicle control. Focal degradation of gelatin still occurs when FAK is inhibited. TNF+Cre+FAKf/fmice treated with tamoxifen were found to have good deletion of FAK in splenocytes. Arthritic mice deficient in FAK did not have significant alterations in arthritis by clinical scoring compared to arthritic mice without FAK deletion.

Conclusion: Consistent with findings in cancer cells, activated FAK is an important component of synovial fibroblast migration and the migratory component of invasion, but not focal matrix degradation. According to clinical arthritis scores, FAK does not appear to play a critical role in arthritis. Studies are ongoing to address if loss of FAK protein, as opposed to FAK inhibition, alters focal gelatin degradation and if joint erosions are altered in arthritis in the absence of FAK, which may be a more specific sign of synovial fibroblast dysfunction than clinical scores.


Disclosure:

M. A. Shelef,
None;

D. Bennin,
None;

A. Huttenlocher,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/role-of-focal-adhesion-kinase-in-synovial-fibroblast-invasion-and-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology